Zhou Sensen, Li Cheng, Yuan Yang, Jiang Lei, Chen Weizhi, Jiang Xiqun
Department of Polymer Science & Engineering, College of Chemistry & Chemical Engineering, and Jiangsu Key Laboratory for Nanotechnology, Nanjing University, Nanjing, 210093, P.R. China.
State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.
Biomater Sci. 2022 Dec 6;10(24):7032-7041. doi: 10.1039/d2bm00952h.
Due to their homing effects, cell and cell membrane-derived nanocarriers have been widely used to enhance drug target delivery. Inspired by the protein-anchored cell membrane architecture, we here report a tumor-targeted liposome, dtDLP, which was constructed through the electrostatic interaction between dendritic lipopeptide liposomes and a dual-targeted recombinant protein, achieving superior tumor homing, cellular endocytotic and penetration abilities. The dual-targeted recombinant protein consists of an anti-epidermal growth factor receptor single domain antibody and a peptide ligand for the integrin αβ. dtDLPs substantially reduced macrophage phagocytosis and increased drug internalization in both 4T1 cells and HeLa cells by providing more endocytic pathways. In addition, the dtDLPs showed great penetration ability in both multicellular spheroids and tumor tissues. Due to the improved cancer cellular uptake and tumor penetration, the dtDLPs exhibited a superior anticancer effect in both HeLa and 4T1 tumor-bearing mice. This work will be helpful for the design of cell-specific liposomes with admirable tumor targeting, endocytotic and penetration abilities.
由于具有归巢效应,细胞及细胞膜衍生的纳米载体已被广泛用于增强药物靶向递送。受蛋白质锚定细胞膜结构的启发,我们在此报告一种肿瘤靶向脂质体dtDLP,它通过树枝状脂肽脂质体与双靶向重组蛋白之间的静电相互作用构建而成,具有卓越的肿瘤归巢、细胞内吞和穿透能力。双靶向重组蛋白由抗表皮生长因子受体单域抗体和整合素αβ的肽配体组成。dtDLP通过提供更多内吞途径,显著减少巨噬细胞吞噬作用,并增加4T1细胞和HeLa细胞中的药物内化。此外,dtDLP在多细胞球体和肿瘤组织中均表现出强大的穿透能力。由于改善了癌细胞摄取和肿瘤穿透能力,dtDLP在荷HeLa和4T1肿瘤小鼠中均表现出卓越的抗癌效果。这项工作将有助于设计具有令人钦佩的肿瘤靶向、内吞和穿透能力的细胞特异性脂质体。